Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William E Gillanders

Showing results (1-10 of 145) with videos related to

Pageof 15
Sort By:
Current Surgery|February 25, 2005
Biliary drainage updateChristophe L Nguyen, William E Gillanders
Breast Cancer (Dove Medical Press)|May 27, 2021
Staging of the Axilla in Breast Cancer and the Evolving Role of Axillary UltrasoundMichael Y Chen, William E Gillanders
Surgical Oncology Clinics of North America|November 20, 2012
Endoscopic and robotic thyroidectomy for cancerJonathan B Mitchem, William E Gillanders
Oncoimmunology|April 9, 2016
Mammaglobin-A is a target for breast cancer vaccinationSamuel W Kim, Peter Goedegebuure, William E Gillanders
Plastic and Reconstructive Surgery|April 28, 2025
Discussion: Breast Implants Elicit Local and Systemic Immune Response: Evidence for Breast Cancer ImmunosurveillanceAlexandra M Keane, William E Gillanders, Terence M Myckatyn
Molecular Cancer Research : MCR|February 5, 2013
EpCAM modulates NF-κB signaling and interleukin-8 expression in breast cancerNarendra V Sankpal, Timothy P Fleming, William E Gillanders
Biomolecules|July 2, 2021
Functional Implications of the Dynamic Regulation of EpCAM during Epithelial-to-Mesenchymal TransitionTaylor C Brown, Narendra V Sankpal, William E Gillanders
The Journal of Surgical Research|June 16, 2009
Dual expression lentiviral vectors for concurrent RNA interference and rescueNarendra V Sankpal, Timothy P Fleming, William E Gillanders
Cancer|January 9, 2009
Racial disparities in the development of breast cancer metastases among older women: a multilevel studyMario Schootman, Donna B Jeffe, William E Gillanders, et al.
Expert Opinion on Investigational Drugs|March 1, 2021
Neoantigen vaccine platforms in clinical development: understanding the future of personalized immunotherapySuangson Supabphol, Lijin Li, S Peter Goedegebuure, et al.
Pageof 15

Showing results (1-10 of 145) with videos related to

Sort By:
Pageof 15
Current Surgery|February 25, 2005
Biliary drainage updateChristophe L Nguyen, William E Gillanders
Breast Cancer (Dove Medical Press)|May 27, 2021
Staging of the Axilla in Breast Cancer and the Evolving Role of Axillary UltrasoundMichael Y Chen, William E Gillanders
Surgical Oncology Clinics of North America|November 20, 2012
Endoscopic and robotic thyroidectomy for cancerJonathan B Mitchem, William E Gillanders
Oncoimmunology|April 9, 2016
Mammaglobin-A is a target for breast cancer vaccinationSamuel W Kim, Peter Goedegebuure, William E Gillanders
Plastic and Reconstructive Surgery|April 28, 2025
Discussion: Breast Implants Elicit Local and Systemic Immune Response: Evidence for Breast Cancer ImmunosurveillanceAlexandra M Keane, William E Gillanders, Terence M Myckatyn
Molecular Cancer Research : MCR|February 5, 2013
EpCAM modulates NF-κB signaling and interleukin-8 expression in breast cancerNarendra V Sankpal, Timothy P Fleming, William E Gillanders
Biomolecules|July 2, 2021
Functional Implications of the Dynamic Regulation of EpCAM during Epithelial-to-Mesenchymal TransitionTaylor C Brown, Narendra V Sankpal, William E Gillanders
The Journal of Surgical Research|June 16, 2009
Dual expression lentiviral vectors for concurrent RNA interference and rescueNarendra V Sankpal, Timothy P Fleming, William E Gillanders
Cancer|January 9, 2009
Racial disparities in the development of breast cancer metastases among older women: a multilevel studyMario Schootman, Donna B Jeffe, William E Gillanders, et al.
Expert Opinion on Investigational Drugs|March 1, 2021
Neoantigen vaccine platforms in clinical development: understanding the future of personalized immunotherapySuangson Supabphol, Lijin Li, S Peter Goedegebuure, et al.
Pageof 15